19 Recruiting Studies Using Inavolisib
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Inavolisib
To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer
📍 Massachusetts General Hospital. — Boston, Massachusetts
Breast Cancer
View Study & Checklist ➔A Study Evaluating Single-agent Inavolisib, Inavolisib Plus Atezolizumab in PIK3CA-Mutated Cancers
📍 Vanderbilt-Ingram Cancer Ctr — Nashville, Tennessee
PIK3CA-Mutated Cancers
View Study & Checklist ➔A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors
📍 UCSF Helen Diller Family CCC — San Francisco, California
Ovarian Cancer
View Study & Checklist ➔A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Non-Small Cell Lung Cancer
View Study & Checklist ➔Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
📍 Western Regional Medical Center at Cancer Treatment Centers of America — Goodyear, Arizona
Solid Tumors
View Study & Checklist ➔A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy
📍 Cancer Blood and Specialty Clinic — Los Alamitos, California
Breast Cancer
View Study & Checklist ➔A Study Evaluating the Efficacy and Safety of Inavolisib + Palbociclib + Fulvestrant vs Placebo + Palbociclib + Fulvestrant in Participants With PIK3CA-Mutant, Hormone Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer
📍 Beverly Hills Cancer Center — Beverly Hills, California
Breast Cancer
View Study & Checklist ➔A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer
📍 Los Angeles Cancer Network — Los Angeles, California
Breast Cancer
View Study & Checklist ➔A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
📍 Los Angeles Cancer Network - Anaheim — Anaheim, California
Breast Cancer
View Study & Checklist ➔A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
📍 City of Hope - Phoenix — Goodyear, Arizona
Breast Cancer
View Study & Checklist ➔A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Endometrial Cancer
View Study & Checklist ➔A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
📍 Banner Health MD Anderson AZ — Gilbert, Arizona
Metastatic Breast Cancer
View Study & Checklist ➔A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study
📍 GHdC Site Les Viviers — Charleroi,
Cancer
View Study & Checklist ➔A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
📍 VA West Los Angeles Medical Center - (CRS) - NAVREF - PPDS — Los Angeles, California
Metastatic Castration-Resistant Prostate Cancer
View Study & Checklist ➔A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
📍 City of Hope — Duarte, California
Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer
View Study & Checklist ➔To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer
📍 Los Angeles Cancer Network — Los Angeles, California
Breast Cancer
View Study & Checklist ➔A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
📍 UAB Comprehensive Cancer Center — Birmingham, Alabama
Metastatic Colorectal Cancer
View Study & Checklist ➔A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
📍 City of Hope — Duarte, California
Metastatic Breast Cancer
View Study & Checklist ➔A Study to Evaluate the Effect of Moderate or Severe Hepatic Impairment on the Pharmacokinetics (PK) of Inavolisib
📍 Orange County Research Center — Lake Forest, California
Hepatic Impairment
View Study & Checklist ➔